Usefulness of the "candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study

Critical Care Medicine

Volumn 37, Issue 5, 2009, Pages 1624-1633

  León, Cristóbal ^a   Ruiz Santana, Sergio ^b   Saavedra, Pedro ^c   Galván, Beatriz ^d   Blanco, Armando ^e,i   Castro, Carmen ^a   Balasini, Carina ^f   Utande Vázquez, Aránzazu ^g   González De Molina, Francisco J ^h   Blasco Navalproto, Miguel A ^l   López, Maria J ^j   Charles, Pierre Emmanuel ^k   Martín, Estrella ^a   Hernández Viera, María Adela ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f Laboratorio Central   (Argentina)

^g HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^h HOSPITAL MÚTUA DE TERRASSA   (Spain)

ⁱ HOSPITAL SEVERO OCHOA   (Spain)

^j HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^k HÔPITAL DU BOCAGE   (France)

^l NONE

more..

Author keywords

Algorithms; Antifungal agents therapeutic use; Candidiasis diagnosis; Critical illness; Fungemia prevention and control; Risk assessment

Indexed keywords

ANTIFUNGAL AGENT; BETA GLUCAN; CANDIDA ANTIBODY; FUNGUS ANTIBODY; UNCLASSIFIED DRUG;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; FUNGAL COLONIZATION; FUNGUS GROWTH; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; INVASIVE CANDIDIASIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SEPSIS; TOTAL PARENTERAL NUTRITION;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; COHORT STUDIES; COLONY COUNT, MICROBIAL; CRITICAL CARE; CRITICAL ILLNESS; FEMALE; FUNGEMIA; HOSPITAL MORTALITY; HUMANS; IMMUNOCOMPETENCE; INTENSIVE CARE UNITS; MALE; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 67650486324     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31819daa14     Document Type: Article

References (35)

1. Pfaller MA, Diekema DJ: Epidemiology of invasive candidiasis: A persistent public health problem. Clin Microbiol Rev 2007; 20: 133-163
2. Garey KW, Rege M, Pai MP, et al: Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study. Clin Infect Dis 2006; 43:25-31
3. Xie GH, Fang XM, Fang Q, et al: Impact of invasive fungal infection on outcomes of severe sepsis: A multicenter matched cohort study in critically ill surgical patients. Crit Care 2008; 12:R5; doi: 10.1186/cc6766
4. Olaechea PM; Palomar M, León-Gil C, et al: Economic impact of Candida colonization and Candida infection in the critically ill patient. Eur J Clin Microbiol Infect Dis 2004; 23:323-330
5. Hof H: Will resistance in fungi emerge on a scale similar to that seen in bacteria? Eur J Clin Microbiol Infect Dis 2008; 27:327-334
6. Charles PE, Dalle F, Aube H, et al: Candida spp. colonization significance in critically ill medical patients: A prospective study. Intensive Care Med 2005; 31:393-400
7. Eggimann P, Garbino J, Pittet D: Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3:685-702
8. Alvarez-Lerma F, Palomar M, León C, et al: Fungal colonization and/or infection in intensive care units: Multicenter study of 1,562 patients. [article in Spanish]. Med Clin (Barc) 2003; 121:161-166
9. Paphitou NI, Ostrosky-Zeichner L, Rex JH: Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: An approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol 2005; 43:235-243
10. Ostrosky-Zeichner L, Sable C, Sobel J, et al: Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007; 26:271-276
11. Dupont H, Bourichon A, Paugam-Burtz C, et al: Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med 2003; 31:752-757
12. Ibáñez-Nolla J, Nolla-Salas M, León MA, et al: Early diagnosis of candidiasis in non-neutropenic critically ill patients. J Infect 2004; 48:181-192
13. Pittet D, Monod M, Suter PM, et al: Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220:751-758
14. Jorda-Marcos R, Álvarez-Lerma F, Jurado M, et al: Risk factors for candidaemia in critically ill patients: A prospective surveillance study. Mycoses 2007; 50:302-310
15. León C, Ruiz-Santana S, Saavedra P, et al: A bedside scoring system ("Candida score") for early antifungal treatment in non-neutro-penic critically ill patients with Candida colonization. Crit Care Med 2006; 34:730-737
16. Maki DG, Weise CE, Sarafin HW: A semi-quantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977; 296:1305-1309
17. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829
18. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure. Intensive Care Med 1996; 22:707-710
19. Levy MM, Fink MP, Marshall JC, et al: 2001 Crit Care Med/ESICM/ACCP/ATS/ SIS International Sepsis Definitions Conference. Intensive Care Med 2003; 29:530-538
20. Philip A, Odabasi Z, Matiuzzi G, et al: Sy-scan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidia-sis. J Clin Microbiol 2005; 43:4834-4835
21. Mermel LA, Farr BM, Sherertz RJ, et al: Guidelines for the management of intravas-cular catheter-related infections. Clin Infect Dis 2001; 32:1249-1272
22. Ascioglu S, Rex JH, de Pauw B, et al: Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002; 34:7-14
23. Rodriguez-Adrián LJ, King RT, Tamayo-Derat LG, et al: Retinal lesions as clues to disseminated bacterial and candidal infections: Frequency, natural history, and etiology. Medicine (Baltimore) 2003; 82:187-202
24. Blumberg HM, Jarvis WR, Soucie JM, et al: Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS prospective multicenter study. Clin Infect Dis 2001; 33:177-186
25. Piarroux R, Grenouillet F, Balvay P, et al: Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 2004; 32: 2443-2449
26. Eggimann P, Pittet D: Postoperative fungal infections. Surg Infect (Larchmt) 2006; 7(Suppl 2):S53-S56
27. Agvald-Öhman C, Klingspor L, Hjelmqvist H, et al: Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome. Scand J Infect Dis 2008; 40:145-153
28. Magill SS, Swoboda SM, Johnson EA, et al: The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients. Diagn Microbiol Infect Dis 2006; 55: 293-301
29. Spellberg BJ, Filler SG, Edwards JE Jr, et al: Current treatment strategies for disseminated candidiasis. Clin Infect Dis 2006; 42:244 -251
30. Vardakas KZ, Samonis G, Michalopoulos A, et al: Antifungal prophylaxis with azoles in high risk, intensive care unit patients: A meta-analysis of randomized placebo-controlled trials. Crit Care Med 2006; 34:1216 -1224
31. Eggimann P, Franciolli P, Bille J, et al: Flu-conazole prophylaxis prevents intra-abdomi-nal candidiasis in high-risk surgical patients. Crit Care Med 1999; 27:1066-1072
32. Pelz RK, Hendrix CW, Swodoba SM, et al: Double-blind placebo-controlled trial of flu-conazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001; 233:542-548
33. Alam FF, Mustafa AS, Khan ZU: Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with can-didemia. BMC Infect Dis 2007; 7:103; doi: 10.1186/1471-2334/7-103
34. Ostrosky-Zeichner L, Alexander BD, Kett DH, et al: Multicenter clinical evaluation of the (1→3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41:654-659
35. Takesue Y, Kakehashi M, Ohge H, et al: Combined assessment of beta-D-glucan and degree of candida colonization before starting empiric therapy for candidiasis in surgical patients. World J Surg 2004; 28: 625-630